Tao Chen1, Guoping Lian2,3, Panayiotis Kattou2. 1. Department of Chemical and Process Engineering, University of Surrey, Guildford, GU2 7XH, UK. t.chen@surrey.ac.uk. 2. Department of Chemical and Process Engineering, University of Surrey, Guildford, GU2 7XH, UK. 3. Unilever Research Colworth, Colworth Park, Sharnbrook, Bedfordshire, MK44 1LQ, UK.
Abstract
PURPOSE: The purpose was to develop a mechanistic mathematical model for predicting the pharmacokinetics of topically applied solutes penetrating through the skin and into the blood circulation. The model could be used to support the design of transdermal drug delivery systems and skin care products, and risk assessment of occupational or consumer exposure. METHODS: A recently reported skin penetration model [Pharm Res 32 (2015) 1779] was integrated with the kinetic equations for dermis-to-capillary transport and systemic circulation. All model parameters were determined separately from the molecular, microscopic and physiological bases, without fitting to the in vivo data to be predicted. Published clinical studies of nicotine were used for model demonstration. RESULTS: The predicted plasma kinetics is in good agreement with observed clinical data. The simulated two-dimensional concentration profile in the stratum corneum vividly illustrates the local sub-cellular disposition kinetics, including tortuous lipid pathway for diffusion and the "reservoir" effect of the corneocytes. CONCLUSIONS: A mechanistic model for predicting transdermal and systemic kinetics was developed and demonstrated with published clinical data. The integrated mechanistic approach has significantly extended the applicability of a recently reported microscopic skin penetration model by providing prediction of solute concentration in the blood.
PURPOSE: The purpose was to develop a mechanistic mathematical model for predicting the pharmacokinetics of topically applied solutes penetrating through the skin and into the blood circulation. The model could be used to support the design of transdermal drug delivery systems and skin care products, and risk assessment of occupational or consumer exposure. METHODS: A recently reported skin penetration model [Pharm Res 32 (2015) 1779] was integrated with the kinetic equations for dermis-to-capillary transport and systemic circulation. All model parameters were determined separately from the molecular, microscopic and physiological bases, without fitting to the in vivo data to be predicted. Published clinical studies of nicotine were used for model demonstration. RESULTS: The predicted plasma kinetics is in good agreement with observed clinical data. The simulated two-dimensional concentration profile in the stratum corneum vividly illustrates the local sub-cellular disposition kinetics, including tortuous lipid pathway for diffusion and the "reservoir" effect of the corneocytes. CONCLUSIONS: A mechanistic model for predicting transdermal and systemic kinetics was developed and demonstrated with published clinical data. The integrated mechanistic approach has significantly extended the applicability of a recently reported microscopic skin penetration model by providing prediction of solute concentration in the blood.
Authors: Thomas J Dursch; Nicole O Taylor; David E Liu; Rong Y Wu; John M Prausnitz; Clayton J Radke Journal: Biomaterials Date: 2013-10-20 Impact factor: 12.479
Authors: Corie A Ellison; Karen L Blackburn; Paul L Carmichael; Harvey J Clewell; Mark T D Cronin; Bertrand Desprez; Sylvia E Escher; Steve S Ferguson; Sébastien Grégoire; Nicola J Hewitt; Heli M Hollnagel; Martina Klaric; Atish Patel; Sabrina Salhi; Andreas Schepky; Barbara G Schmitt; John F Wambaugh; Andrew Worth Journal: Regul Toxicol Pharmacol Date: 2019-01-15 Impact factor: 3.271
Authors: Rodrigo Boscariol; José M Oliveira Junior; Denicezar A Baldo; Victor M Balcão; Marta M D C Vila Journal: Saudi Pharm J Date: 2022-02-04 Impact factor: 4.562